| 1 | Lissencephaly | Enrichment | ACTG1, TUBA1A, TUBA3E, TUBB, TUBB2B, TUBB3, TUBG1 | 10.81 |
| 2 | Genetic steroid-resistant nephrotic syndrome | Enrichment | NUP107, NUP133, NUP160, NUP205, NUP37, NUP85, NUP93 | 9.16 |
| 3 | Tubulinopathy | Enrichment | RALGAPB, TUBA1A, TUBB2A, TUBB2B | 9.08 |
| 4 | Tubulinopathy-associated dysgyria | Enrichment | TUBA1A, TUBB2B, TUBB3 | 8.56 |
| 5 | Congenital fibrosis of the extraocular muscles | Enrichment | TUBA1A, TUBB2B, TUBB3 | 7.26 |
| 6 | Pachyonychia congenita 1 | Enrichment | KRT16, KRT17, KRT6A | 6.65 |
| 7 | Catecholaminergic polymorphic ventricular tachycardia | Enrichment | CALM1, CALM2, CALM3 | 6.27 |
| 8 | Epidermolysis bullosa simplex 2f, with mottled pigmentation | Enrichment | KRT14, KRT5, PLEC | 6.25 |
| 9 | Epidermolysis bullosa simplex 1a, generalized severe | Enrichment | KRT14, KRT5, PLEC | 6.25 |
| 10 | Epidermolysis bullosa simplex | Enrichment | KRT14, KRT5, PLEC | 5.71 |
| 11 | Baraitser-winter cerebrofrontofacial syndrome | Enrichment | ACTB, ACTG1 | 5.24 |
| 12 | Emery-dreifuss muscular dystrophy 1, x-linked | Enrichment | EMD, LMNA | 4.95 |
| 13 | Emery-dreifuss muscular dystrophy | Enrichment | EMD, LMNA | 4.95 |
| 14 | Epidermolysis bullosa simplex 1d, generalized, intermediate or severe, autosomal recessive | Enrichment | KRT14, KRT5 | 4.82 |
| 15 | White sponge nevus | Enrichment | KRT13, KRT4 | 4.82 |
| 16 | Long qt syndrome 1 | Enrichment | CALM1, CALM2, CALM3 | 4.42 |
| 17 | Polymicrogyria, bilateral perisylvian, x-linked | Enrichment | TUBA1A, TUBB2B | 4.36 |
| 18 | Palmoplantar keratoderma, epidermolytic, 1 | Enrichment | KRT1, KRT16 | 4.35 |
| 19 | Keratosis palmoplantaris striata | Enrichment | DSP, KRT1 | 4.35 |
| 20 | Cryptogenic cirrhosis | Enrichment | KRT18, KRT8 | 4.35 |
| 21 | Cataract 6, multiple types | Enrichment | CHMP4B, LEMD2 | 4.24 |
| 22 | Bilateral perisylvian polymicrogyria | Enrichment | TUBA1A, TUBB2B | 4.13 |
| 23 | Skin disease | Enrichment | KRT14, KRT17, PLEC | 4.08 |
| 24 | Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss | Enrichment | MYH9, TUBB1 | 4.06 |
| 25 | Epidermolysis bullosa simplex 1b, generalized intermediate | Enrichment | KRT14, KRT5 | 4.05 |
| 26 | Epidermolysis bullosa simplex generalized type | Enrichment | KRT14, KRT5 | 4.05 |
| 27 | Autosomal dominant macrothrombocytopenia | Enrichment | TUBA8, TUBB1 | 4.03 |
| 28 | Cerebral palsy | Enrichment | SPAST, TUBA1A, TUBB4A | 3.95 |
| 29 | Epidermolytic hyperkeratosis 1 | Enrichment | KRT1, KRT2 | 3.83 |
| 30 | Epidermolysis bullosa simplex 1c, localized | Enrichment | KRT14, KRT5 | 3.83 |
| 31 | Familial infantile bilateral striatal necrosis | Enrichment | NUP54, NUP62 | 3.72 |
| 32 | Microcephaly | Enrichment | ACTB, ACTG1, CTNNB1, TUBB4A | 3.67 |
| 33 | Inherited arrhythmogenic cardiomyopathy | Enrichment | DSP, PKP2 | 3.65 |
| 34 | Neuromuscular disease | Enrichment | EMD, LMNA | 3.55 |
| 35 | Neuropathy, hereditary motor and sensory, okinawa type | Enrichment | EMD, LMNA | 3.50 |
| 36 | Arrhythmogenic right ventricular dysplasia, familial, 9 | Enrichment | DSP, PKP2 | 3.28 |
| 37 | Familial isolated arrhythmogenic right ventricular dysplasia | Enrichment | DSP, PKP2 | 3.28 |
| 38 | Inherited isolated arrhythmogenic ventricular dysplasia, biventricular variant | Enrichment | DSP, PKP2 | 3.02 |
| 39 | Inherited isolated arrhythmogenic cardiomyopathy, dominant-left variant | Enrichment | DSP, PKP2 | 3.02 |
| 40 | Multiple sclerosis | Enrichment | DST, PLEC | 2.88 |
| 41 | Inherited isolated arrhythmogenic cardiomyopathy, dominant-right variant | Enrichment | DSP, PKP2 | 2.88 |
| 42 | Galloway-mowat syndrome | Enrichment | NUP107, NUP133 | 2.86 |
| 43 | Leukodystrophy, demyelinating, adult-onset, autosomal dominant, typical | Enrichment | LMNB1 | 2.85 |
| 44 | Buschke-ollendorff syndrome | Enrichment | LEMD3 | 2.85 |
| 45 | Teeth, supernumerary | Enrichment | LEMD2 | 2.85 |
| 46 | Greenberg dysplasia | Enrichment | LBR | 2.85 |
| 47 | Pelger-huet anomaly | Enrichment | LBR | 2.85 |
| 48 | Microcephaly 16, primary, autosomal recessive | Enrichment | ANKLE2 | 2.85 |
| 49 | Rhizomelic skeletal dysplasia with or without pelger-huet anomaly | Enrichment | LBR | 2.85 |
| 50 | Marbach-rustad progeroid syndrome | Enrichment | LEMD2 | 2.85 |
| 51 | Adult onset demyelinating leukodystrophy | Enrichment | LMNB1 | 2.85 |
| 52 | Houge-janssens syndrome 2 | Enrichment | PPP2R1A | 2.85 |
| 53 | Nestor-guillermo progeria syndrome | Enrichment | BANF1 | 2.85 |
| 54 | Microcephaly 26, primary, autosomal dominant | Enrichment | LMNB1 | 2.85 |
| 55 | Reynolds syndrome | Enrichment | LBR | 2.85 |
| 56 | Atypical werner syndrome | Enrichment | LMNA | 2.85 |
| 57 | Neuronopathy, distal hereditary motor, autosomal recessive 10 | Enrichment | VRK1 | 2.85 |
| 58 | Melorheostosis with osteopoikilosis | Enrichment | LEMD3 | 2.85 |
| 59 | Mandibuloacral dysplasia | Enrichment | LMNA | 2.85 |
| 60 | Atrioventricular block | Enrichment | LMNA | 2.85 |
| 61 | Lmna-related cardiocutaneous progeria syndrome | Enrichment | LMNA | 2.85 |
| 62 | Isolated osteopoikilosis | Enrichment | LEMD3 | 2.85 |
| 63 | Ppp2r1a-related neurodevelopmental disorder | Enrichment | PPP2R1A | 2.85 |
| 64 | Autosomal semi-dominant severe lipodystrophic laminopathy | Enrichment | LMNA | 2.85 |
| 65 | Microcephaly-complex motor and sensory axonal neuropathy syndrome | Enrichment | VRK1 | 2.85 |
| 66 | Autosomal recessive axonal hereditary motor and sensory neuropathy | Enrichment | LMNA | 2.85 |
| 67 | Laminopathy | Enrichment | LMNA | 2.85 |
| 68 | Palmoplantar keratoderma and congenital alopecia 1 | Enrichment | GJA1 | 2.83 |
| 69 | Hypoplastic left heart syndrome 1 | Enrichment | GJA1 | 2.83 |
| 70 | Fibrosis of extraocular muscles, congenital, 3a, with or without extraocular involvement | Enrichment | TUBB3 | 2.83 |
| 71 | Oculodentodigital dysplasia | Enrichment | GJA1 | 2.83 |
| 72 | Macrothrombocytopenia, isolated, 1, autosomal dominant | Enrichment | TUBB1 | 2.83 |
| 73 | Craniometaphyseal dysplasia, autosomal recessive | Enrichment | GJA1 | 2.83 |
| 74 | Leber congenital amaurosis with early-onset deafness | Enrichment | TUBB4B | 2.83 |
| 75 | Oocyte/zygote/embryo maturation arrest 24 | Enrichment | TUBA1C | 2.83 |
| 76 | Oculodentodigital dysplasia, autosomal recessive | Enrichment | GJA1 | 2.83 |
| 77 | Cortical dysplasia, complex, with other brain malformations 7 | Enrichment | TUBB2B | 2.83 |
| 78 | Oocyte/zygote/embryo maturation arrest 23 | Enrichment | TUBA4A | 2.83 |
| 79 | Frontotemporal dementia and/or amyotrophic lateral sclerosis 9 | Enrichment | TUBA4A | 2.83 |
| 80 | Erythrokeratodermia variabilis et progressiva 3 | Enrichment | GJA1 | 2.83 |
| 81 | Facial palsy, congenital, with ptosis and velopharyngeal dysfunction | Enrichment | TUBB6 | 2.83 |
| 82 | Macrothrombocytopenia, isolated, 2, autosomal dominant | Enrichment | TUBA8 | 2.83 |
| 83 | Lissencephaly due to tuba1a mutation | Enrichment | TUBA1A | 2.83 |
| 84 | Congenital myopathy 26 | Enrichment | TUBA4A | 2.83 |
| 85 | Spastic ataxia 11, autosomal dominant | Enrichment | TUBA4A | 2.83 |
| 86 | Amyotrophic lateral sclerosis type 22 | Enrichment | TUBA4A | 2.83 |
| 87 | Polymicrogyria with optic nerve hypoplasia | Enrichment | TUBA8 | 2.83 |
| 88 | Type 2 diabetes mellitus | Enrichment | AKT2, SLC2A4, TBC1D4 | 2.81 |
| 89 | Bart-pumphrey syndrome | Enrichment | GJB2 | 2.81 |
| 90 | Vohwinkel syndrome | Enrichment | GJB2 | 2.81 |
| 91 | Deafness, autosomal dominant 3a | Enrichment | GJB2 | 2.81 |
| 92 | Keratitis-ichthyosis-deafness syndrome, autosomal dominant | Enrichment | GJB2 | 2.81 |
| 93 | Ichthyosis, hystrix-like, with deafness | Enrichment | GJB2 | 2.81 |
| 94 | Porokeratotic eccrine ostial and dermal duct nevus | Enrichment | GJB2 | 2.81 |
| 95 | Autosomal dominant nonsyndromic hearing loss 3a | Enrichment | GJB2 | 2.81 |
| 96 | Hypoparathyroidism-retardation-dysmorphism syndrome | Enrichment | TBCE | 2.77 |
| 97 | Kenny-caffey syndrome, type 1 | Enrichment | TBCE | 2.77 |
| 98 | Encephalopathy, progressive, with amyotrophy and optic atrophy | Enrichment | TBCE | 2.77 |
| 99 | Early-onset progressive encephalopathy-spastic ataxia-distal spinal muscular atrophy syndrome | Enrichment | TBCE | 2.77 |
| 100 | Arrhythmogenic right ventricular cardiomyopathy | Enrichment | DSP, PKP2 | 2.76 |
| 101 | Long qt syndrome | Enrichment | CALM1, CALM2 | 2.68 |
| 102 | Congenital nervous system abnormality | Enrichment | CTNNB1, TUBA1A, TUBB4A | 2.67 |
| 103 | Nervous system disease | Enrichment | CTNNB1, TUBA1A, TUBB4A | 2.67 |
| 104 | Cardiomyopathy, familial hypertrophic, 6 | Enrichment | PRKAG2 | 2.66 |
| 105 | Glycogen storage disease of heart, lethal congenital | Enrichment | PRKAG2 | 2.66 |
| 106 | Long qt syndrome 16 | Enrichment | CALM3 | 2.66 |
| 107 | Skeletal muscle glycogen content and metabolism quantitative trait locus | Enrichment | PRKAG3 | 2.66 |
| 108 | Long qt syndrome 15 | Enrichment | CALM2 | 2.66 |
| 109 | Baraitser-winter syndrome 1 | Enrichment | ACTB | 2.61 |
| 110 | Macular dystrophy, patterned, 2 | Enrichment | CTNNA1 | 2.61 |
| 111 | Congenital smooth muscle hamartoma, with or without hemihypertrophy | Enrichment | ACTB | 2.61 |
| 112 | Adrenal cortical adenoma | Enrichment | MEN1 | 2.61 |
| 113 | Becker nevus syndrome | Enrichment | ACTB | 2.61 |
| 114 | Dystonia-deafness syndrome 1 | Enrichment | ACTB | 2.61 |
| 115 | Takenouchi-kosaki syndrome | Enrichment | CDC42 | 2.61 |
| 116 | Thrombocytopenia 8, with dysmorphic features and developmental delay | Enrichment | ACTB | 2.61 |
| 117 | Adenoid ameloblastoma | Enrichment | CTNNB1 | 2.61 |
| 118 | Baraitser-winter syndrome | Enrichment | ACTB | 2.61 |
| 119 | Adrenal adenoma | Enrichment | MEN1 | 2.61 |
| 120 | Congenital smooth muscle hamartoma | Enrichment | ACTB | 2.61 |
| 121 | Nocarh syndrome | Enrichment | CDC42 | 2.61 |
| 122 | Developmental malformations-deafness-dystonia syndrome | Enrichment | ACTB | 2.61 |
| 123 | Microcephaly-corpus callosum and cerebellar vermis hypoplasia-facial dysmorphism-intellectual disability syndrom | Enrichment | RAC1 | 2.61 |
| 124 | Microcystic stromal tumor | Enrichment | CTNNB1 | 2.61 |
| 125 | Cataract 31, multiple types | Enrichment | CHMP4B | 2.61 |
| 126 | Familial isolated dilated cardiomyopathy | Enrichment | LMNA, TMPO | 2.61 |
| 127 | Cataract 46, juvenile-onset, with or without arrhythmic cardiomyopathy | Enrichment | LEMD2 | 2.55 |
| 128 | Mandibuloacral dysplasia with type a lipodystrophy | Enrichment | LMNA | 2.55 |
| 129 | Myopathy, x-linked, with postural muscle atrophy | Enrichment | EMD | 2.55 |
| 130 | Heart-hand syndrome, slovenian type | Enrichment | LMNA | 2.55 |
| 131 | Pontocerebellar hypoplasia, type 1a | Enrichment | VRK1 | 2.55 |
| 132 | Charcot-marie-tooth disease, axonal, type 2b1 | Enrichment | LMNA | 2.55 |
| 133 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism | Enrichment | LMNA | 2.55 |
| 134 | Cardiomyopathy, dilated, 1d | Enrichment | LMNA | 2.55 |
| 135 | Restrictive dermopathy 2 | Enrichment | LMNA | 2.55 |
| 136 | Emery-dreifuss muscular dystrophy 3, autosomal recessive | Enrichment | LMNA | 2.55 |
| 137 | Cataract 46 juvenile-onset | Enrichment | LEMD2 | 2.55 |
| 138 | Lipodystrophy, familial partial, type 1 | Enrichment | LMNA | 2.55 |
| 139 | Osteopoikilosis | Enrichment | LEMD3 | 2.55 |
| 140 | Autosomal dominant primary microcephaly | Enrichment | LMNB1 | 2.55 |
| 141 | Congenital pontocerebellar hypoplasia type 1 | Enrichment | VRK1 | 2.55 |
| 142 | Houge-janssens syndrome 3 | Enrichment | PPP2CA | 2.55 |
| 143 | Familial partial lipodystrophy | Enrichment | LMNA | 2.55 |
| 144 | 12q14 microdeletion syndrome | Enrichment | LEMD3 | 2.55 |
| 145 | Charcot-marie-tooth disease type 2b1 | Enrichment | LMNA | 2.55 |
| 146 | X-linked emery-dreifuss muscular dystrophy | Enrichment | EMD | 2.55 |
| 147 | Rare autosomal dominant non-syndromic sensorineural deafness type dfna | Enrichment | ACTG1, MYH9, MYO1C | 2.55 |
| 148 | Dystonia 4, torsion, autosomal dominant | Enrichment | TUBB4A | 2.53 |
| 149 | Hallermann-streiff syndrome | Enrichment | GJA1 | 2.53 |
| 150 | Muscular dystrophy, limb-girdle, autosomal recessive 3 | Enrichment | TUBA1A | 2.53 |
| 151 | Syndactyly, type iii | Enrichment | GJA1 | 2.53 |
| 152 | Syndactyly, type v | Enrichment | GJA1 | 2.53 |
| 153 | Keratoconus 9 | Enrichment | TUBA3D | 2.53 |
| 154 | Autosomal recessive limb-girdle muscular dystrophy type 2d | Enrichment | TUBA1A | 2.53 |
| 155 | Craniometaphyseal dysplasia | Enrichment | GJA1 | 2.53 |
| 156 | Lissencephaly 3 | Enrichment | TUBA1A | 2.53 |
| 157 | Cortical dysplasia, complex, with other brain malformations 1 | Enrichment | TUBB3 | 2.53 |
| 158 | Torsion dystonia 4 | Enrichment | TUBB4A | 2.53 |
| 159 | Continuous spikes and waves during sleep | Enrichment | TUBA1A | 2.53 |
| 160 | Deafness, autosomal recessive 104 | Enrichment | GJB2 | 2.51 |
| 161 | Deafness, autosomal recessive 1b | Enrichment | GJB2 | 2.51 |
| 162 | Keratitis ichthyosis and deafness syndrome | Enrichment | GJB2 | 2.51 |
| 163 | Hereditary palmoplantar keratoderma | Enrichment | GJB2 | 2.51 |
| 164 | Corneal dystrophy, fuchs endothelial, 8 | Enrichment | AGBL1 | 2.49 |
| 165 | Neurodevelopmental disorder with ataxia, hypotonia, and microcephaly | Enrichment | SVBP | 2.49 |
| 166 | Motor peripheral neuropathy | Enrichment | AGTPBP1 | 2.49 |
| 167 | Cone-rod dystrophy 19 | Enrichment | TTLL5 | 2.49 |
| 168 | Retinitis pigmentosa 75 | Enrichment | AGBL5 | 2.49 |
| 169 | Isolated congenital microcephaly | Enrichment | RAB11A, TUBA3E | 2.47 |
| 170 | Muscular dystrophy-dystroglycanopathy , type a, 11 | Enrichment | TBCE | 2.47 |
| 171 | Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum | Enrichment | TBCD | 2.47 |
| 172 | Seborrhea-like dermatitis with psoriasiform elements | Enrichment | TBCD | 2.47 |
| 173 | Congenital muscular dystrophy-dystroglycanopathy type a11 | Enrichment | TBCE | 2.47 |
| 174 | Ichthyosis hystrix, curth-macklin type | Enrichment | KRT1 | 2.41 |
| 175 | Dermatopathia pigmentosa reticularis | Enrichment | KRT14 | 2.41 |
| 176 | Skin creases, congenital symmetric circumferential, 1 | Enrichment | TUBB | 2.41 |
| 177 | Pachyonychia congenita 2 | Enrichment | KRT17 | 2.41 |
| 178 | Palmoplantar keratoderma, nonepidermolytic | Enrichment | KRT1 | 2.41 |
| 179 | Ectodermal dysplasia/skin fragility syndrome | Enrichment | PKP1 | 2.41 |
| 180 | Ichthyosis bullosa of siemens | Enrichment | KRT2 | 2.41 |
| 181 | Naegeli-franceschetti-jadassohn syndrome | Enrichment | KRT14 | 2.41 |
| 182 | Cortical dysplasia, complex, with other brain malformations 6 | Enrichment | TUBB | 2.41 |
| 183 | Pachyonychia congenita 3 | Enrichment | KRT6A | 2.41 |
| 184 | Steatocystoma multiplex | Enrichment | KRT17 | 2.41 |
| 185 | White sponge nevus 1 | Enrichment | KRT4 | 2.41 |
| 186 | Ichthyosis, annular epidermolytic, 2 | Enrichment | KRT1 | 2.41 |
| 187 | Palmoplantar keratoderma, nonepidermolytic, focal or diffuse | Enrichment | KRT6C | 2.41 |
| 188 | Keratosis palmoplantaris striata iii | Enrichment | KRT1 | 2.41 |
| 189 | White sponge nevus 2 | Enrichment | KRT13 | 2.41 |
| 190 | Developmental and epileptic encephalopathy 56 | Enrichment | YWHAG | 2.41 |
| 191 | Skin fragility-woolly hair-palmoplantar keratoderma syndrome | Enrichment | DSP | 2.41 |
| 192 | Palmoplantar keratoderma, epidermolytic, 2 | Enrichment | KRT1 | 2.41 |
| 193 | Focal palmoplantar keratoderma | Enrichment | KRT6C | 2.41 |
| 194 | Qualitative or quantitative defects of plectin | Enrichment | PLEC | 2.41 |
| 195 | Premature aging | Enrichment | VIM | 2.41 |
| 196 | Restrictive dermopathy 1 | Enrichment | LMNA | 2.38 |
| 197 | Lipodystrophy, familial partial, type 2 | Enrichment | LMNA | 2.38 |
| 198 | Muscular dystrophy, congenital, lmna-related | Enrichment | LMNA | 2.38 |
| 199 | Pontocerebellar hypoplasia, type 1b | Enrichment | VRK1 | 2.38 |
| 200 | Restrictive dermopathy | Enrichment | LMNA | 2.38 |
| 201 | Leukodystrophy, hypomyelinating, 6 | Enrichment | TUBB4A | 2.35 |
| 202 | Oocyte/zygote/embryo maturation arrest 2 | Enrichment | TUBB8 | 2.35 |
| 203 | Cortical dysplasia, complex, with other brain malformations 5 | Enrichment | TUBB2A | 2.35 |
| 204 | Ventricular tachycardia, catecholaminergic polymorphic, 4 | Enrichment | CALM1 | 2.35 |
| 205 | Long qt syndrome 14 | Enrichment | CALM1 | 2.35 |
| 206 | Keratoderma, palmoplantar, with deafness | Enrichment | GJB2 | 2.33 |
| 207 | Ifap syndrome 1, with or without bresheck syndrome | Enrichment | GJB2 | 2.33 |
| 208 | Deafness, x-linked 2 | Enrichment | GJB2 | 2.33 |
| 209 | X-linked mixed hearing loss with perilymphatic gusher | Enrichment | GJB2 | 2.33 |
| 210 | Osteopathia striata with cranial sclerosis | Enrichment | CTNNB1 | 2.31 |
| 211 | Hyperparathyroidism 1 | Enrichment | MEN1 | 2.31 |
| 212 | Deafness, autosomal dominant 20 | Enrichment | ACTG1 | 2.31 |
| 213 | Baraitser-winter syndrome 2 | Enrichment | ACTG1 | 2.31 |
| 214 | Intellectual developmental disorder, autosomal dominant 48 | Enrichment | RAC1 | 2.31 |
| 215 | Childhood hepatocellular carcinoma | Enrichment | CTNNB1 | 2.31 |
| 216 | Medullary thyroid carcinoma | Enrichment | MEN1 | 2.31 |
| 217 | Immune system disease | Enrichment | CDC42 | 2.31 |
| 218 | Insulinoma | Enrichment | MEN1 | 2.31 |
| 219 | Juvenile nasopharyngeal angiofibroma | Enrichment | CTNNB1 | 2.31 |
| 220 | Teratoma | Enrichment | CTNNB1 | 2.31 |
| 221 | Null pituitary adenoma | Enrichment | MEN1 | 2.31 |
| 222 | Silent pituitary adenoma | Enrichment | MEN1 | 2.31 |
| 223 | Gigantism | Enrichment | MEN1 | 2.31 |
| 224 | Cimdag syndrome | Enrichment | VPS4A | 2.31 |
| 225 | Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma 1 | Enrichment | ARL2 | 2.29 |
| 226 | Proteus syndrome | Enrichment | AKT1 | 2.26 |
| 227 | Hypoinsulinemic hypoglycemia with hemihypertrophy | Enrichment | AKT2 | 2.26 |
| 228 | Deafness, autosomal dominant 17 | Enrichment | MYH9 | 2.26 |
| 229 | Type 2 diabetes 5 | Enrichment | TBC1D4 | 2.26 |
| 230 | Griscelli syndrome, type 1 | Enrichment | MYO5A | 2.26 |
| 231 | Elejalde neuroectodermal melanolysosomal syndrome | Enrichment | MYO5A | 2.26 |
| 232 | Hiatt-neu-cooper neurodevelopmental syndrome | Enrichment | RALA | 2.26 |
| 233 | Neurodevelopmental disorder with hypotonia and autistic features with or without hyperkinetic movements | Enrichment | VAMP2 | 2.26 |
| 234 | Deafness, autosomal recessive 123 | Enrichment | STX4 | 2.26 |
| 235 | Cowden syndrome 6 | Enrichment | AKT1 | 2.26 |
| 236 | Retinitis pigmentosa 89 | Enrichment | KIF3B | 2.26 |
| 237 | Neurodevelopmental disorder with seizures and brain atrophy | Enrichment | EXOC7 | 2.26 |
| 238 | Neurodevelopmental disorder with microcephaly, seizures, and brain atrophy | Enrichment | EXOC8 | 2.26 |
| 239 | Autosomal dominant nonsyndromic hearing loss 17 | Enrichment | MYH9 | 2.26 |
| 240 | Distal 17p13.3 microdeletion syndrome | Enrichment | YWHAE | 2.26 |
| 241 | Akt2-related familial partial lipodystrophy | Enrichment | AKT2 | 2.26 |
| 242 | Dilated cardiomyopathy | Enrichment | EMD, LMNA | 2.26 |
| 243 | Hutchinson-gilford progeria syndrome | Enrichment | LMNA | 2.25 |
| 244 | Microtia-anotia | Enrichment | LMNA | 2.25 |
| 245 | Charcot-marie-tooth hereditary neuropathy | Enrichment | VRK1 | 2.25 |
| 246 | Sick sinus syndrome | Enrichment | LMNA | 2.25 |
| 247 | Neurodevelopmental disorder with achalasia, polyneuropathy, and alacrima | Enrichment | NDC1 | 2.25 |
| 248 | Atrial fibrillation, familial, 15 | Enrichment | NUP155 | 2.25 |
| 249 | Dystonia 37, early-onset, with striatal lesions | Enrichment | NUP54 | 2.25 |
| 250 | Nephrotic syndrome, type 19 | Enrichment | NUP160 | 2.25 |
| 251 | Orofacial cleft 10 | Enrichment | SUMO1 | 2.25 |
| 252 | Galloway-mowat syndrome 8 | Enrichment | NUP133 | 2.25 |
| 253 | Nephrotic syndrome, type 13 | Enrichment | NUP205 | 2.25 |
| 254 | Microcephaly 24, primary, autosomal recessive | Enrichment | NUP37 | 2.25 |
| 255 | Galloway-mowat syndrome 7 | Enrichment | NUP107 | 2.25 |
| 256 | Nephrotic syndrome, type 12 | Enrichment | NUP93 | 2.25 |
| 257 | Nephrotic syndrome, type 11 | Enrichment | NUP107 | 2.25 |
| 258 | Sandestig-stefanova syndrome | Enrichment | NUP188 | 2.25 |
| 259 | Ovarian dysgenesis 6 | Enrichment | NUP107 | 2.25 |
| 260 | Nephrotic syndrome, type 18 | Enrichment | NUP133 | 2.25 |
| 261 | Infection-induced acute-onset axonal neuropathy | Enrichment | RCC1 | 2.25 |
| 262 | Deafness, autosomal recessive 1a | Enrichment | GJB2 | 2.21 |
| 263 | Gjb2-related autosomal recessive nonsyndromic hearing loss | Enrichment | GJB2 | 2.21 |
| 264 | Neurodevelopmental disorder with cerebellar atrophy and with or without seizures | Enrichment | AGTPBP1 | 2.19 |
| 265 | Glycine encephalopathy 2 | Enrichment | NICN1 | 2.19 |
| 266 | Neurodegeneration, childhood-onset, with cerebellar atrophy | Enrichment | AGTPBP1 | 2.19 |
| 267 | Autosomal recessive limb-girdle muscular dystrophy type 2b | Enrichment | LMNA | 2.16 |
| 268 | Spinal muscular atrophy | Enrichment | VRK1 | 2.16 |
| 269 | Histiocytoid hemangioma | Enrichment | LMNA | 2.16 |
| 270 | Desmoid disease, hereditary | Enrichment | CTNNB1 | 2.14 |
| 271 | Neurodevelopmental disorder with spastic diplegia and visual defects | Enrichment | CTNNB1 | 2.14 |
| 272 | Pituitary adenoma 1, multiple types | Enrichment | MEN1 | 2.14 |
| 273 | Anus, imperforate | Enrichment | CTNNB1 | 2.14 |
| 274 | Exudative vitreoretinopathy 7 | Enrichment | CTNNB1 | 2.14 |
| 275 | Desmoid tumor | Enrichment | CTNNB1 | 2.14 |
| 276 | Cellular ependymoma | Enrichment | MEN1 | 2.14 |
| 277 | Tanycytic ependymoma | Enrichment | MEN1 | 2.14 |
| 278 | Papillary ependymoma | Enrichment | MEN1 | 2.14 |
| 279 | Parathyroid adenoma | Enrichment | MEN1 | 2.14 |
| 280 | Growth hormone secreting pituitary adenoma | Enrichment | MEN1 | 2.14 |
| 281 | Aip familial isolated pituitary adenomas | Enrichment | MEN1 | 2.14 |
| 282 | Butterfly-shaped pigment dystrophy | Enrichment | CTNNA1 | 2.14 |
| 283 | Familial isolated hyperparathyroidism | Enrichment | MEN1 | 2.14 |
| 284 | Clear cell ependymoma | Enrichment | MEN1 | 2.14 |
| 285 | Spastic paraplegia 2, x-linked | Enrichment | SPAST | 2.14 |
| 286 | Cleft upper lip | Enrichment | GJA1 | 2.13 |
| 287 | Female infertility due to oocyte meiotic arrest | Enrichment | TUBB8 | 2.13 |
| 288 | Epidermolysis bullosa simplex 5a, ogna type | Enrichment | PLEC | 2.11 |
| 289 | Epidermolysis bullosa simplex 5b, with muscular dystrophy | Enrichment | PLEC | 2.11 |
| 290 | Arrhythmogenic right ventricular dysplasia, familial, 8 | Enrichment | DSP | 2.11 |
| 291 | Keratoderma, palmoplantar, with nail dystrophy and hereditary motor-sensory neuropathy | Enrichment | KRT1 | 2.11 |
| 292 | Epidermolysis bullosa simplex 2e, with migratory circinate erythema | Enrichment | KRT5 | 2.11 |
| 293 | Muscular dystrophy, limb-girdle, autosomal recessive 17 | Enrichment | PLEC | 2.11 |
| 294 | Keratosis palmoplantaris striata ii | Enrichment | DSP | 2.11 |
| 295 | Palmoplantar keratoderma, nonepidermolytic, focal 1 | Enrichment | KRT16 | 2.11 |
| 296 | Cortical dysplasia, complex, with other brain malformations 4 | Enrichment | TUBG1 | 2.11 |
| 297 | Cardiomyopathy, dilated, with woolly hair, keratoderma, and tooth agenesis | Enrichment | DSP | 2.11 |
| 298 | Epidermolysis bullosa simplex 2d, generalized, intermediate or severe, autosomal recessive | Enrichment | KRT5 | 2.11 |
| 299 | Sjogren-larsson syndrome | Enrichment | KRT14 | 2.11 |
| 300 | Autosomal recessive limb-girdle muscular dystrophy type 2q | Enrichment | PLEC | 2.11 |
| 301 | Progressive familial heart block | Enrichment | DSP | 2.11 |
| 302 | Cataract 30 | Enrichment | VIM | 2.11 |
| 303 | Cardiomyopathy, dilated, with woolly hair and keratoderma | Enrichment | DSP | 2.11 |
| 304 | Epidermolysis bullosa simplex 2a, generalized severe | Enrichment | KRT5 | 2.11 |
| 305 | Multiple benign circumferential skin creases on limbs | Enrichment | TUBB | 2.11 |
| 306 | Hereditary breast ovarian cancer syndrome | Enrichment | CTNNA1, MEN1 | 2.10 |
| 307 | Left ventricular noncompaction | Enrichment | DSP, PKP2 | 2.09 |
| 308 | Rare autosomal recessive non-syndromic sensorineural deafness type dfnb | Enrichment | GJA1, GJB2 | 2.08 |
| 309 | Emery-dreifuss muscular dystrophy 2, autosomal dominant | Enrichment | LMNA | 2.08 |
| 310 | Pontocerebellar hypoplasia, type 1e | Enrichment | VRK1 | 2.08 |
| 311 | Cerebellar ataxia, impaired intellectual development, and dysequilibrium syndrome 1 | Enrichment | TUBB2B | 2.05 |
| 312 | Early myoclonic encephalopathy | Enrichment | TUBA1A | 2.05 |
| 313 | Deafness, autosomal recessive 12 | Enrichment | GJB2 | 2.03 |
| 314 | Diffuse gastric and lobular breast cancer syndrome | Enrichment | CTNNA1 | 2.01 |
| 315 | Polyposis syndrome, hereditary mixed, 1 | Enrichment | CTNNA1 | 2.01 |
| 316 | Pilomatrixoma | Enrichment | CTNNB1 | 2.01 |
| 317 | Aminoacylase 1 deficiency | Enrichment | ACTB | 2.01 |
| 318 | Alazami syndrome | Enrichment | CTNNB1 | 2.01 |
| 319 | Craniopharyngioma | Enrichment | CTNNB1 | 2.01 |
| 320 | Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia | Enrichment | CDC42 | 2.01 |
| 321 | Prolactinoma | Enrichment | MEN1 | 2.01 |
| 322 | Primary hyperparathyroidism | Enrichment | MEN1 | 2.01 |
| 323 | Benign ependymoma | Enrichment | MEN1 | 2.01 |
| 324 | Pseudomyogenic hemangioendothelioma | Enrichment | ACTB | 2.01 |
| 325 | Bethlem myopathy 1a | Enrichment | LMNA | 2.01 |
| 326 | Cataract 35 | Enrichment | MYH9 | 1.96 |
| 327 | Alveolar soft part sarcoma | Enrichment | ASPSCR1 | 1.96 |
| 328 | Griscelli syndrome, type 3 | Enrichment | MYO5A | 1.96 |
| 329 | Pseudosarcomatous fibromatosis | Enrichment | MYH9 | 1.96 |
| 330 | Neurodevelopmental disorder with dysmorphic facies and cerebellar hypoplasia | Enrichment | EXOC2 | 1.96 |
| 331 | Congenital muscular dystrophy | Enrichment | LMNA | 1.95 |
| 332 | Myocarditis | Enrichment | LMNA | 1.95 |
| 333 | Striatonigral degeneration, infantile | Enrichment | NUP62 | 1.95 |
| 334 | Nephronophthisis-like nephropathy 1 | Enrichment | RANGAP1 | 1.95 |
| 335 | Nephrotic syndrome, type 17 | Enrichment | NUP85 | 1.95 |
| 336 | Nail disorder, nonsyndromic congenital, 4 | Enrichment | KRT17 | 1.93 |
| 337 | Peeling skin syndrome 4 | Enrichment | KRT2 | 1.93 |
| 338 | Ichthyosis with confetti | Enrichment | KRT1 | 1.93 |
| 339 | Epidermolysis bullosa, lethal acantholytic | Enrichment | DSP | 1.93 |
| 340 | Ichthyosis, annular epidermolytic, 1 | Enrichment | KRT1 | 1.93 |
| 341 | Epidermolysis bullosa simplex 3, localized or generalized intermediate, with bp230 deficiency | Enrichment | DST | 1.93 |
| 342 | Erythroderma, congenital, with palmoplantar keratoderma, hypotrichosis, and hyper-ige | Enrichment | DSP | 1.93 |
| 343 | Woolly hair-skin fragility syndrome | Enrichment | DSP | 1.93 |
| 344 | Epidermolysis bullosa simplex 2b, generalized intermediate | Enrichment | KRT5 | 1.93 |
| 345 | Epidermolysis bullosa simplex 5d, generalized intermediate, autosomal recessive | Enrichment | PLEC | 1.93 |
| 346 | Epidermolysis bullosa simplex 2c, localized | Enrichment | KRT5 | 1.93 |
| 347 | Annular epidermolytic ichthyosis | Enrichment | KRT1 | 1.93 |
| 348 | Autosomal dominant epidermolytic ichthyosis | Enrichment | KRT1 | 1.93 |
| 349 | Erythrokeratodermia variabilis et progressiva 1 | Enrichment | GJA1 | 1.93 |
| 350 | Cryptorchidism | Enrichment | TUBA1A | 1.93 |
| 351 | Hypoplastic left heart syndrome | Enrichment | GJA1 | 1.93 |
| 352 | Exudative vitreoretinopathy 1 | Enrichment | CTNNB1 | 1.92 |
| 353 | Coloboma of choroid and retina | Enrichment | ACTG1 | 1.92 |
| 354 | Spastic diplegia | Enrichment | SPAST | 1.92 |
| 355 | Leukoencephalopathy with vanishing white matter | Enrichment | ANKLE2 | 1.90 |
| 356 | Juvenile amyotrophic lateral sclerosis | Enrichment | VRK1 | 1.90 |
| 357 | Cryptorchidism, unilateral or bilateral | Enrichment | TUBA1A | 1.88 |
| 358 | Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy | Enrichment | CALM1 | 1.88 |
| 359 | Difference of sex development | Enrichment | TBCE | 1.87 |
| 360 | Primary autosomal recessive microcephaly | Enrichment | ANKLE2, NUP37 | 1.85 |
| 361 | Weyers acrofacial dysostosis | Enrichment | CTNNB1 | 1.84 |
| 362 | Adrenocortical carcinoma | Enrichment | CTNNB1 | 1.84 |
| 363 | Dowling-degos disease 1 | Enrichment | KRT5 | 1.81 |
| 364 | Epidermolysis bullosa simplex 5c, with pyloric atresia | Enrichment | PLEC | 1.81 |
| 365 | Neuropathy, hereditary sensory and autonomic, type vi | Enrichment | DST | 1.81 |
| 366 | Dowling-degos disease | Enrichment | KRT5 | 1.81 |
| 367 | Epidermolytic hyperkeratosis | Enrichment | KRT1 | 1.81 |
| 368 | Choroidal dystrophy, central areolar, 1 | Enrichment | TTLL5 | 1.79 |
| 369 | Fuchs' endothelial dystrophy | Enrichment | AGBL1 | 1.79 |
| 370 | Miller-dieker lissencephaly syndrome | Enrichment | YWHAE | 1.79 |
| 371 | Chromosome 17p13.3, centromeric, duplication syndrome | Enrichment | YWHAE | 1.79 |
| 372 | Cardiac conduction defect | Enrichment | LMNA | 1.78 |
| 373 | Muscular dystrophy, limb-girdle, autosomal recessive 2 | Enrichment | LMNA | 1.78 |
| 374 | Multiple endocrine neoplasia, type i | Enrichment | MEN1 | 1.77 |
| 375 | Gastrointestinal stromal tumor | Enrichment | MEN1 | 1.77 |
| 376 | Gallbladder cancer | Enrichment | CTNNB1 | 1.77 |
| 377 | Semantic dementia | Enrichment | CHMP2B | 1.77 |
| 378 | Congenital hypothyroidism | Enrichment | TUBB1 | 1.76 |
| 379 | Catecholaminergic polymorphic ventricular tachycardia 1 | Enrichment | CALM1 | 1.76 |
| 380 | Colorectal cancer | Enrichment | CTNNA1, CTNNB1 | 1.72 |
| 381 | Exudative vitreoretinopathy | Enrichment | CTNNB1 | 1.71 |
| 382 | Spastic paraplegia 4, autosomal dominant | Enrichment | SPAST | 1.71 |
| 383 | Early-onset posterior polar cataract | Enrichment | CHMP4B | 1.71 |
| 384 | Glycine encephalopathy | Enrichment | NICN1 | 1.71 |
| 385 | Arrhythmogenic right ventricular dysplasia, familial, 1 | Enrichment | PKP2 | 1.71 |
| 386 | Chromosome 15q11.2 deletion syndrome | Enrichment | TUBG1 | 1.71 |
| 387 | Cardiac arrest | Enrichment | DSP | 1.71 |
| 388 | Epidermolysis bullosa | Enrichment | KRT5 | 1.71 |
| 389 | Arrhythmogenic right ventricular dysplasia 1 | Enrichment | PKP2 | 1.71 |
| 390 | Aplasia cutis congenita | Enrichment | PLEC | 1.71 |
| 391 | Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies | Enrichment | RAC1 | 1.66 |
| 392 | Adult hepatocellular carcinoma | Enrichment | CTNNB1 | 1.66 |
| 393 | Progressive non-fluent aphasia | Enrichment | CHMP2B | 1.66 |
| 394 | Behavioral variant of frontotemporal dementia | Enrichment | CHMP2B | 1.66 |
| 395 | Corpus callosum, agenesis of | Enrichment | TUBA1A | 1.66 |
| 396 | Isolated corpus callosum agenesis | Enrichment | TUBA1A | 1.66 |
| 397 | Intellectual disability-hypoplastic corpus callosum-preauricular tag syndrome | Enrichment | TUBA1A | 1.66 |
| 398 | Epidermolysis bullosa, junctional 5b, with pyloric atresia | Enrichment | PLEC | 1.63 |
| 399 | Cardiomyopathy, dilated, 1e | Enrichment | LMNA | 1.63 |
| 400 | Cataract 44 | Enrichment | LEMD2 | 1.63 |
| 401 | Cat eye syndrome | Enrichment | ACTG1 | 1.62 |
| 402 | Dandy-walker syndrome | Enrichment | TUBA1A | 1.61 |
| 403 | Pontocerebellar hypoplasia | Enrichment | VRK1 | 1.60 |
| 404 | Glycine encephalopathy 1 | Enrichment | NICN1 | 1.59 |
| 405 | Arteriovenous malformations of the brain | Enrichment | LEMD3 | 1.58 |
| 406 | Diabetes mellitus | Enrichment | MEN1 | 1.58 |
| 407 | Deafness, autosomal recessive 63 | Enrichment | MYH9 | 1.57 |
| 408 | Endometrial stromal sarcoma | Enrichment | YWHAE | 1.57 |
| 409 | Thrombocytopenia | Enrichment | MYH9, TUBB1 | 1.55 |
| 410 | Cardiomyopathy, dilated, 1a | Enrichment | LMNA | 1.54 |
| 411 | Autosomal dominant non-syndromic intellectual disability | Enrichment | RAB11A, YWHAZ | 1.52 |
| 412 | Lennox-gastaut syndrome | Enrichment | MAPK10 | 1.51 |
| 413 | Hemangioma, capillary infantile | Enrichment | MYH9 | 1.49 |
| 414 | Breast adenocarcinoma | Enrichment | AKT1 | 1.49 |
| 415 | Kidney clear cell sarcoma | Enrichment | YWHAE | 1.49 |
| 416 | Cardiomyopathy, familial hypertrophic, 1 | Enrichment | LMNA | 1.48 |
| 417 | Muscular dystrophy | Enrichment | LMNA | 1.48 |
| 418 | Medulloblastoma | Enrichment | CTNNB1 | 1.47 |
| 419 | Jeune thoracic dystrophy | Enrichment | LBR | 1.46 |
| 420 | Wolff-parkinson-white syndrome | Enrichment | PRKAG2 | 1.46 |
| 421 | Noonan syndrome 1 | Enrichment | GJB2 | 1.46 |
| 422 | Brugada syndrome | Enrichment | LMNA | 1.45 |
| 423 | Ear malformation | Enrichment | GJB2 | 1.44 |
| 424 | Sudden infant death syndrome | Enrichment | CALM2 | 1.43 |
| 425 | Renal cell carcinoma with mit translocations | Enrichment | ASPSCR1 | 1.43 |
| 426 | Auditory neuropathy | Enrichment | TUBB4A | 1.42 |
| 427 | Hypertension | Enrichment | MEN1 | 1.42 |
| 428 | Cataract 30, multiple types | Enrichment | VIM | 1.42 |
| 429 | Asphyxiating thoracic dystrophy | Enrichment | LBR | 1.41 |
| 430 | Polycystic liver disease | Enrichment | CTNNB1 | 1.39 |
| 431 | Autosomal dominant polycystic liver disease | Enrichment | CTNNB1 | 1.39 |
| 432 | Inherited cancer-predisposing syndrome | Enrichment | CTNNA1, MEN1 | 1.39 |
| 433 | Specific learning disability | Enrichment | YWHAG | 1.38 |
| 434 | Peripheral nervous system disease | Enrichment | LMNA | 1.36 |
| 435 | Neuropathy | Enrichment | LMNA | 1.36 |
| 436 | Short-rib thoracic dysplasia 1 with or without polydactyly | Enrichment | LBR | 1.34 |
| 437 | Craniosynostosis | Enrichment | CTNNA1 | 1.32 |
| 438 | Cowden syndrome | Enrichment | AKT1 | 1.32 |
| 439 | Aortic valve disease 1 | Enrichment | DSP | 1.30 |
| 440 | Hepatoblastoma | Enrichment | CTNNB1 | 1.30 |
| 441 | Hepatocellular carcinoma | Enrichment | CTNNB1 | 1.28 |
| 442 | Fetal akinesia deformation sequence 1 | Enrichment | TUBA1A | 1.27 |
| 443 | Non-syndromic genetic deafness | Enrichment | GJB2 | 1.27 |
| 444 | Myopathy | Enrichment | EMD | 1.26 |
| 445 | Charcot-marie-tooth disease | Enrichment | LMNA | 1.25 |
| 446 | Hydrocephalus, congenital, 1 | Enrichment | TUBB | 1.22 |
| 447 | Optic atrophy plus syndrome | Enrichment | TUBB6 | 1.20 |
| 448 | West syndrome | Enrichment | TUBA1A | 1.20 |
| 449 | Nonsyndromic hearing loss | Enrichment | GJB2 | 1.20 |
| 450 | Septooptic dysplasia | Enrichment | RALGAPB | 1.20 |
| 451 | Meningioma | Enrichment | AKT1 | 1.20 |
| 452 | Interstitial lung disease 2 | Enrichment | DSP | 1.19 |
| 453 | 46 xx gonadal dysgenesis | Enrichment | NUP107 | 1.18 |
| 454 | Bladder cancer | Enrichment | CTNNB1 | 1.17 |
| 455 | Rare genetic deafness | Enrichment | ACTG1, MYH9 | 1.16 |
| 456 | Familial hypertrophic cardiomyopathy | Enrichment | PRKAG2 | 1.15 |
| 457 | Sensorineural hearing loss | Enrichment | GJB2 | 1.14 |
| 458 | Spastic ataxia | Enrichment | TUBB3 | 1.12 |
| 459 | Seckel syndrome | Enrichment | NUP85 | 1.12 |
| 460 | Cakut | Enrichment | ACTG1 | 1.10 |
| 461 | Cardiomyopathy, dilated, 1g | Enrichment | DSP | 1.08 |
| 462 | Hypertrophic cardiomyopathy | Enrichment | PRKAG2 | 1.04 |
| 463 | Deafness, autosomal recessive | Enrichment | GJB2 | 1.03 |
| 464 | Autosomal recessive nonsyndromic deafness | Enrichment | GJB2 | 1.02 |
| 465 | Hereditary spastic paraplegia | Enrichment | SPAST | 1.01 |
| 466 | Focal segmental glomerulosclerosis | Enrichment | NUP93 | 0.97 |
| 467 | Tooth agenesis | Enrichment | SUMO1 | 0.93 |
| 468 | Familial atrial fibrillation | Enrichment | NUP155 | 0.89 |
| 469 | Leber plus disease | Enrichment | TUBB4B | 0.88 |
| 470 | Autosomal recessive non-syndromic intellectual disability | Enrichment | CLIP1 | 0.88 |
| 471 | Frontotemporal dementia and/or amyotrophic lateral sclerosis 7 | Enrichment | CHMP2B | 0.88 |
| 472 | Meckel syndrome, type 1 | Enrichment | EXOC4 | 0.83 |
| 473 | Retinitis pigmentosa | Enrichment | AGBL5, TTLL5 | 0.82 |
| 474 | Hirschsprung disease 1 | Enrichment | NUP98 | 0.82 |
| 475 | Autism spectrum disorder | Enrichment | GJB2 | 0.81 |
| 476 | Complex neurodevelopmental disorder | Enrichment | PPP2CA | 0.80 |
| 477 | Dystonia | Enrichment | MYO5A | 0.76 |
| 478 | Undetermined early-onset epileptic encephalopathy | Enrichment | YWHAG | 0.71 |
| 479 | Cone-rod dystrophy 2 | Enrichment | TTLL5 | 0.70 |
| 480 | Hereditary breast carcinoma | Enrichment | AKT1 | 0.67 |
| 481 | Nephrotic syndrome | Enrichment | NUP93 | 0.66 |
| 482 | Ovarian cancer | Enrichment | CTNNB1 | 0.66 |
| 483 | Body mass index quantitative trait locus 11 | Enrichment | MYH9 | 0.62 |
| 484 | Hereditary retinal dystrophy | Enrichment | AGBL5, TTLL5 | 0.62 |
| 485 | Fundus dystrophy | Enrichment | AGBL5, TTLL5 | 0.62 |
| 486 | Breast cancer | Enrichment | AKT1 | 0.47 |